Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17284046rdf:typepubmed:Citationlld:pubmed
pubmed-article:17284046lifeskim:mentionsumls-concept:C0002505lld:lifeskim
pubmed-article:17284046lifeskim:mentionsumls-concept:C0030015lld:lifeskim
pubmed-article:17284046lifeskim:mentionsumls-concept:C0596040lld:lifeskim
pubmed-article:17284046lifeskim:mentionsumls-concept:C0332514lld:lifeskim
pubmed-article:17284046lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:17284046pubmed:issue5lld:pubmed
pubmed-article:17284046pubmed:dateCreated2007-2-23lld:pubmed
pubmed-article:17284046pubmed:abstractText[reaction: see text] Asymmetric allylic amination of allylic carbonates prepared from racemic Morita-Baylis-Hillman adducts proceeded in the presence of Pd catalyst, chiral diaminophosphine oxide (DIAPHOX), and BSA, affording the corresponding chiral aza-Morita-Baylis-Hillman adduct derivatives in excellent yield with up to 99% ee. The cyclic reaction products could be converted into various synthetically useful compounds such as chiral cyclic beta-amino acids.lld:pubmed
pubmed-article:17284046pubmed:languageenglld:pubmed
pubmed-article:17284046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17284046pubmed:citationSubsetIMlld:pubmed
pubmed-article:17284046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17284046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17284046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17284046pubmed:statusMEDLINElld:pubmed
pubmed-article:17284046pubmed:monthMarlld:pubmed
pubmed-article:17284046pubmed:issn1523-7060lld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:TamuraShinjiSlld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:YamamotoEriElld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:NemotoTetsuhi...lld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:HamadaYasumas...lld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:FukudaTomoaki...lld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:MatsumotoTaka...lld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:FukuyamaTakas...lld:pubmed
pubmed-article:17284046pubmed:authorpubmed-author:AkimotoYuichi...lld:pubmed
pubmed-article:17284046pubmed:issnTypePrintlld:pubmed
pubmed-article:17284046pubmed:day1lld:pubmed
pubmed-article:17284046pubmed:volume9lld:pubmed
pubmed-article:17284046pubmed:ownerNLMlld:pubmed
pubmed-article:17284046pubmed:authorsCompleteYlld:pubmed
pubmed-article:17284046pubmed:pagination927-30lld:pubmed
pubmed-article:17284046pubmed:meshHeadingpubmed-meshheading:17284046...lld:pubmed
pubmed-article:17284046pubmed:meshHeadingpubmed-meshheading:17284046...lld:pubmed
pubmed-article:17284046pubmed:meshHeadingpubmed-meshheading:17284046...lld:pubmed
pubmed-article:17284046pubmed:meshHeadingpubmed-meshheading:17284046...lld:pubmed
pubmed-article:17284046pubmed:meshHeadingpubmed-meshheading:17284046...lld:pubmed
pubmed-article:17284046pubmed:meshHeadingpubmed-meshheading:17284046...lld:pubmed
pubmed-article:17284046pubmed:year2007lld:pubmed
pubmed-article:17284046pubmed:articleTitlePd-catalyzed asymmetric allylic amination of Morita-Baylis-Hillman adduct derivatives using chiral diaminophosphine oxides: DIAPHOXs.lld:pubmed
pubmed-article:17284046pubmed:affiliationGraduate School of Pharmaceutical Sciences, Chiba University, Chiba 263-8522, Japan.lld:pubmed
pubmed-article:17284046pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17284046pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed